Dr. Culig is currently Associate Professor at Innsbruck Medical University. He has received MD degree from University of Zagreb, Republic of Croatia. His research interest is in mechanisms relevant to development and progression of human carcinoma of the prostate. In this context, expression and function of androgen receptor and its partner proteins coactivators has been studied. Androgen receptor is also activated by interleukin-6, a pleiotropic cytokine whose levels are elevated in carcinoma of the prostate. Current research is focused on growth regulation by interleukin-6. We have identified novel functions of suppressors of cytokine signaling in prostate cancer. These proteins have a prominent function in regulation of proliferation and apoptosis.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)